From the Exhibitors' Hall: SNMMI Annual Meeting 2015.

I n previous years, overviews of the Exhibitors’ Hall at the SNMMI Annual Meeting (in Miami, FL, 2012; Vancouver, Canada, 2013; and St. Louis, MO, 2014) have highlighted established patient-focused developments and service products. This year, we looked at the 2015 Exhibitors’ Hall in Baltimore, MD, from a slightly different perspective. The preclinical arena is central to drug discovery, instrumentation development, and software applications that can ultimately transition into clinical care. New radiopharmaceuticals are initially tested in animals, and new imaging methods (hybrid camera designs and new modalities) are first reported in preclinical animal trials. A focus on the latest preclinical developments in molecular imaging and therapy shown at the 2015 SNMMI Annual Meeting allows us to look into the future and predict innovations that may expand scientific knowledge and enhance patient care.